Glyxer M 2 Tablet SR is a sustained-release oral antidiabetic medication containing a combination of Glimepiride 2 mg and Metformin 500 mg. This formulation is indicated for the management of type 2 diabetes mellitus, particularly in patients inadequately controlled by diet and exercise alone. Glimepiride, a sulfonylurea class agent, acts by stimulating pancreatic beta cells to increase insulin secretion, thereby lowering blood glucose levels. Metformin, a biguanide, primarily reduces hepatic glucose production and improves peripheral insulin sensitivity, contributing to enhanced glycemic control. The sustained-release formulation of Glyxer M 2 Tablet SR ensures a gradual release of active ingredients, promoting better tolerability and reducing gastrointestinal side effects commonly associated with immediate-release metformin. This combination therapy offers complementary mechanisms of action, addressing multiple pathophysiological defects in type 2 diabetes. Glyxer M 2 Tablet SR should be administered as prescribed, typically once daily with meals to minimize gastrointestinal discomfort. Regular monitoring of blood glucose levels, renal function, and other metabolic parameters is recommended during treatment. Caution is advised in patients with renal impairment, hepatic dysfunction, or conditions predisposing to lactic acidosis. Overall, Glyxer M 2 Tablet SR is an effective therapeutic option for improving glycemic control in adults with type 2 diabetes mellitus.

Dosage & How to Use